Target intelligence / Profile preview

Ribosomal protein L29 pseudogene 29 (RPL29P29)

Target: RPL29P29
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein L29 pseudogene 29 is a processed pseudogene derived from the ribosomal protein L29 gene (RPL29). Pseudogenes are DNA sequences that resemble functional genes but are generally non-functional due to mutations, truncations, or lack of regulatory elements, and do not produce a functional protein. RPL29P29 does not encode any protein and has no recognized biological function or disease association. Multiple ribosomal protein pseudogenes exist throughout the human genome as remnants of retrotransposition events and are not considered valid pharmacological or diagnostic targets.

Other names: RPL29_18_1328RPL29P29

Beyond the preview

Go deeper on Ribosomal protein L29 pseudogene 29 (RPL29P29).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L29 pseudogene 29 (RPL29P29).

Explore the full profile